The Mounjaro Logo: What It Looks Like and What It Tells You About Genuine Pens

What the official Mounjaro logo and packaging actually look like

Eli Lilly's Mounjaro branding centres on a blue oval containing the word "Mounjaro" in clean white lettering. On the pen body itself, the logo sits alongside the strength label (for example, "2.5 mg/0.5 mL solution for injection") and the Eli Lilly wordmark. The outer carton repeats this, adds the full product description in English, and includes the UK marketing authorisation details. Every genuine pack also carries the Black Triangle (▼) symbol, which the NHS tirzepatide medicines page explains signals that Mounjaro is subject to additional post-market monitoring by the MHRA, this is normal for newer medicines and is a mark of regulatory oversight, not cause for alarm.

Colour-coding matters too. Eli Lilly assigns each of the six UK strengths its own distinct colour band on the label and pen cap: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg each look different at a glance. If the colour on your pen doesn't correspond to the strength printed on the label, that's worth querying with your pharmacy immediately. These design choices aren't decorative, they're a patient-safety feature to reduce dosing errors.

One thing to keep in mind: Eli Lilly does occasionally refresh packaging design, so minor variations between production batches are normal. What should never change is the presence of a UK marketing authorisation number, English-language product information, and a dispensing label from a GPhC-registered pharmacy.

Why the logo matters when buying Mounjaro online

The MHRA has issued repeated public warnings about counterfeit weight-loss pens circulating in the UK. In October 2025 enforcement officers raided a site in Northampton that was producing fake tirzepatide pens, and across 2025 approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million were seized nationally. Fake pens have in some cases contained insulin rather than the stated active ingredient, a potentially life-threatening substitution.

Counterfeit packaging often mimics the tirzepatide logo well enough to pass a casual glance, but what fake products consistently fail to replicate correctly are the finer details: the UK marketing authorisation number, the batch code format, the dispensing label, and the physical pen mechanism. If you're sourcing Mounjaro through a registered online pharmacy, your pen will arrive with a patient-specific prescription label attached. If there is no such label, or if the price seemed far below the typical UK market range, those are meaningful red flags. You can verify any online pharmacy on the GPhC pharmacy register before you order. Report anything suspicious via the MHRA Yellow Card scheme, which accepts reports of both suspected side effects and suspect sellers.

We understand the instinct to check these things carefully, being sent something that doesn't look quite right is unsettling, especially with a medicine you're injecting weekly. If you have any doubt about a pen you've received, contact the dispensing pharmacy before using it.

Mounjaro's clinical background: what the evidence says

It's worth knowing why the logo has become so recognisable in the first place. Tirzepatide, the active ingredient in Mounjaro, is a dual GIP and GLP-1 receptor agonist, the only weight-management medicine in the UK that acts on both pathways. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, adults without diabetes taking tirzepatide at the 15 mg dose achieved around 20–21% average body-weight reduction over 72 weeks, alongside a reduced-calorie diet and increased activity. That scale of evidence, replicated across thousands of participants in the wider SURMOUNT programme, is what drove the NICE recommendation for tirzepatide (TA1026) published in December 2024.

Treatment starts at 2.5 mg, a tolerability dose, adjusted upward by a prescriber in roughly four-week steps as your system settles. The Mounjaro KwikPen delivers four weekly doses from a single pen, which is why each pen is designed for a month of treatment. Understanding this schedule helps you spot packaging inconsistencies: a pen claiming to contain a dose combination that doesn't exist in the licensed UK schedule is a useful warning sign. For details on how the Mounjaro 2.5 mg starting dose works and what to expect from it, as well as the complete prescribing schedule and storage requirements, the Mounjaro Summary of Product Characteristics on the electronic Medicines Compendium (eMC) is the authoritative reference.

If you're exploring what starting treatment looks like (from eligibility through to how the doses progress) the Mounjaro treatment overview covers the full picture, or you can read about tirzepatide as an active ingredient in its own right.

Checking eligibility and accessing genuine treatment

Mounjaro is licensed for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone never guarantees approval, a prescriber assesses the whole clinical picture, including current medicines, medical history and weight-management goals.

If you're considering treatment, the eligibility guide for Mounjaro is a clear starting point. For context on what private treatment costs and how pricing works in the UK, the treatment options page sets out what's included. At nume, every consultation is read by a GPhC-registered Independent Prescriber (a named clinician, not automated software) and genuine Mounjaro from the licensed UK supply chain is dispensed through our own GPhC-registered pharmacy (registration number 9012878, verifiable here). Pens arrive the next working day via DPD in plain packaging, with a prescription label that confirms the dispensing pharmacy.

You can also read about buying Mounjaro online safely, or explore the weight-loss treatment options more broadly if you're still deciding which medicine might suit your situation.